Onchocerca parasites and Wolbachia endosymbionts: evaluation of a spectrum of antibiotic types for activity against Onchocerca gutturosa in vitro by Townson, Simon et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
Filaria Journal
Open Access Research
Onchocerca parasites and Wolbachia endosymbionts: evaluation of 
a spectrum of antibiotic types for activity against Onchocerca 
gutturosa in vitro
Simon Townson*1, Senyo Tagboto1, Helen F McGarry2, Gillian L Egerton2 
and Mark J Taylor2
Address: 1Tropical Parasitic Diseases Unit, Northwick Park Institute for Medical Research, Watford Road, Harrow, Middlesex HA1 3UJ, UK and 
2Filariasis Research Laboratory, Molecular and Biochemical Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 
5QA, UK
Email: Simon Townson* - s.townson@imperial.ac.uk; Senyo Tagboto - senyo.tagboto@uhns.nhs.uk; 
Helen F McGarry - Helen.McGarry@hse.gsi.gov.uk; Gillian L Egerton - gillegerton@msn.com; Mark J Taylor - mark.taylor@liv.ac.uk
* Corresponding author    
Abstract
Background:  The filarial parasites of major importance in humans contain the symbiotic
bacterium Wolbachia and recent studies have shown that targeting of these bacteria with antibiotics
results in a reduction in worm viability, development, embryogenesis, and survival. Doxycycline has
been effective in human trials, but there is a need to develop drugs that can be given for shorter
periods and to pregnant women and children. The World Health Organisation-approved assay to
screen for anti-filarial activity in vitro uses male Onchocerca gutturosa, with effects being determined
by worm motility and viability as measured by reduction of MTT to MTT formazan. Here we have
used this system to screen antibiotics for anti-filarial activity. In addition we have determined the
contribution of Wolbachia depletion to the MTT reduction assay.
Methods: Adult male O. gutturosa were cultured on a monkey kidney cell (LLCMK 2) feeder layer
in 24-well plates with antibiotics and antibiotic combinations (6 to 10 worms per group). The
macrofilaricide CGP 6140 (Amocarzine) was used as a positive control. Worm viability was
assessed by two methods, (i) motility levels and (ii) MTT/formazan colorimetry. Worm motility was
scored on a scale of 0 (immotile) to 10 (maximum) every 5 days up to 40 days. On day 40 worm
viability was evaluated by MTT/formazan colorimetry, and results were expressed as a mean
percentage reduction compared with untreated control values at day 40. To determine the
contribution of Wolbachia to the MTT assay, the MTT formazan formation of an insect cell-line (C6/
36) with or without insect Wolbachia infection and treated or untreated with tetracycline was
compared.
Results: Antibiotics with known anti-Wolbachia activity were efficacious in this system. Rifampicin
(5 × 10-5M) was the most effective anti-mycobacterial agent; clofazimine (1.25 × 10-5M and 3.13 ×
10-6M) produced a gradual reduction in motility and by 40 days had reduced worm viability. The
other anti-mycobacterial drugs tested had limited or no activity. Doxycycline (5 × 10-5M) was
filaricidal, but minocycline was more effective and at a lower concentration (5 × 10-5M and 1.25 ×
10-5M). Inactive compounds included erythromycin, oxytetracycline, trimethoprim and
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sulphamethoxazole. The MTT assay on the insect cell-line showed that Wolbachia made a significant
contribution to the metabolic activity within the cells, which could be reduced when they were
exposed to tetracycline.
Conclusion: The O. gutturosa adult male screen for anti-filarial drug activity is also valid for the
screening of antibiotics for anti-Wolbachia activity. In agreement with previous findings, rifampicin
and doxycycline were effective; however, the most active antibiotic was minocycline. Wolbachia
contributed to the formation of MTT formazan in the MTT assay of viability and is therefore not
exclusively a measure of worm viability and indicates that Wolbachia contributes directly to the
metabolic activity of the nematode.
Background
The control of human filariasis caused by Brugia malayi,
Wuchereria bancrofti and  Onchocerca volvulus, currently
relies on community-wide mass distribution of ivermec-
tin and albendazole, either individually or in combina-
tion with diethylcarbamazine. Unfortunately, these drugs
are mainly microfilaricidal rather than macrofilaricidal,
which means that repeated treatment is required over
many years, and the possibility that resistance to them
may develop is a cause for concern [1-3]. However, with
the realisation that many filarial nematodes, including
those responsible for most of the global burden of human
filarial disease, are infected with Wolbachia [4], has pro-
vided an alternative approach to the treatment and con-
trol of these parasites with antibiotics.
Wolbachia are intracellular bacteria that have a mutualistic
relationship with their nematode hosts [4] and studies
have shown that antibiotics can eliminate the bacteria and
result in worm growth retardation, infertility and reduced
viability [5-8]; conversely, nematodes not infected with
Wolbachia  were unaffected by antibiotic exposure [5].
Recent field trials of the antibiotics oxytetracycline against
onchocerciasis in cattle [9] and of doxycycline in human
onchocerciasis [10-12] and W. bancrofti infection [13,14]
have demonstrated the validity of this approach. In all
cases, treatment resulted in a pronounced reduction in
microfilaraemia/microfilaridermia and a prolonged inhi-
bition of embryogenesis, but, significantly, an eight week
course of doxycycline 200 mg daily also proved to be mac-
rofilaricidal against W. bancrofti [13]. The administration
of antibiotics may also have benefits in addition to their
sterilising effects and killing of worms; Wolbachia are asso-
ciated with the pathology of filarial infections [15-17] and
with adverse reactions to diethylcarbamazine and iver-
mectin [18,19]. A recent study has shown that a three
week course of doxycycline can lead to a sustained ami-
crofilaraemia but does not result in macrofilaricidal activ-
ity [20].
Although antibiotics have a valuable activity against filar-
ial nematodes, the long treatment regimens that are
required present logistical problems for mass drug admin-
istration (MDA). Another obstacle to MDA is the contra-
indication of tetracyclines in pregnant women and chil-
dren under the age of eight years. Therefore, alternative
treatment options that target Wolbachia but circumvent
these problems would be advantageous. For more than 18
years, an in vitro drug screen for identifying potential mac-
rofilaricidal activity has used adult male O. gutturosa [21-
23], with assessment of efficacy being made by observing
worm motility and inhibition of MTT formazan forma-
tion [24,25]. In the present work we have extended this
system and developed a long-term assay, which has ena-
bled us to screen many of the commonly used antibiotics
for macrofilaricidal activity, both individually and in
combinations. We have also determined the contribution
of Wolbachia to the MTT assay.
Methods
In vitro drug screen
Adult male O. gutturosa were dissected from the nuchal
ligament connective tissues obtained from naturally
infected cattle in Kumasi, Ghana, as previously described
[6]. They were maintained individually in the wells of a
24-well plate containing 1.8 ml of Minimum Essential
Medium with 10% heat inactivated calf serum and a mon-
key kidney cell (LLCMK2) feeder layer [26] at 36.5°C with
5% CO2 for 24 to 48 hours until the addition of drugs. The
medium of all wells included the antibiotics penicillin
(200 U/ml) and streptomycin (200 µg/ml), which have
no anti-Wolbachia activity [27], and the anti-mycotic agent
amphotericin B (50 µg/ml). Drugs were prepared as previ-
ously described [6] in medium and each drug concentra-
tion was tested against six to ten worms, maintained as
above. Medium (with or without drug) was replaced every
5 days. The compounds tested included a range of test
antibiotics (Tables 1, 2 and 3), both individually and in
combination. The amoscanate derivative CGP 6140
(Amocarzine) was used as a positive control since it is
macrofilaricidal against Onchocerca  parasites [28],
reviewed by [29].
Worm viability was measured by the motility levels and
MTT colorimetry. Motility scores were assessed on an
inverted microscope on a scale of 0 (immotile) to 10Filaria Journal 2006, 5:4 http://www.filariajournal.com/content/5/1/4
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(maximum) [22] at regular intervals up to 40 days. The
biochemical evaluation of worm viability was carried out
by MTT/formazan colorimetry on day 40. In this assay, the
yellow compound MTT [3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide] is reduced by the mito-
chondrial enzyme succinate dehydrogenase of living tis-
sues to produce the blue precipitate MTT formazan
[24,25]. Single intact worms were placed in each well of a
48-well plate (Falcon, UK) containing 0.5 ml of 0.5 mg/
ml MTT (Sigma, UK) in phosphate buffered saline, and
incubated for 30 minutes at 37°C. The worms were then
transferred to separate wells of a 96 well plate, each con-
taining 200 µl of dimethyl sulphoxide to solubilize the
formazan. After one hour the plate was gently agitated to
disperse the colour evenly and the absorbance value (opti-
cal density) of the resulting formazan solution was deter-
mined at 490 nm on an ELISA reader. Inhibition of
formazan formation is correlated with worm damage or
death. The motility and MTT assay results were expressed
as a mean percentage reduction compared with untreated
control values at day 40. Comparisons of test groups to
untreated controls for both motility levels and MTT color-
imetry on day 40 were carried out using a 2-sample t-test.
Contribution of Wolbachia to the MTT reduction assay
Since the B. malayi and Drosophila melanogaster Wolbachia
genomes contain genes for succinate dehydrogenase [30],
the mosquito cell-line C6/36 was used to investigate the
contribution of Wolbachia to the MTT reduction assay. C6/
36 is derived from Aedes albopictus larvae and is not natu-
rally infected with Wolbachia. However, it can be easily
infected with Wolbachia from the cell-line Aa23, which is
Table 2: Summary of long-term trial 2: parasite mean motility scores and viability (MTT colorimetry) 
Compound/drug and conc. Mean motility scores over a period of 40 days Motility MTT
D A Y 1 5 1 01 52 02 53 03 54 0 %  r e d u c t i o n  o n  
day 40 (P)
% inhibition on day 
40 (P)
Control 7.6 7.2 7.1 6.8 5.9 4.9 5.8 6.1 6.3
aCGP 6140 1.25 × 10-5M (positive control) 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.0 (ND) 87.2 (ND)
bNorfloxacin 5 × 10-5M 6.9 7.4 7.1 2.4 2.5 2.6 1.4 1.0 2.5 60.3 (ND) 90.7 (ND)
Ciprofloxacin 5 × 10-5M 6.9 7.9 7.1 3.6 4.1 3.0 2.3 2.5 3.0 52.4 (0.080) 73.3 (0.040)
Vancomycin 5 × 10-5M 6.4 7.4 6.5 3.6 3.6 2.8 2.4 1.6 2.1 66.7 (0.009) 83.7 (0.022)
Gentamycin 5 × 10-5M 7.6 5.5 6.3 2.8 2.6 0.8 1.5 1.0 1.6 74.6 (0.005) 83.7 (0.017)
Ceftriaxone 5 × 10-5M 7.1 6.8 7.0 2.4 2.0 0.9 0.6 0.6 0.7 88.9 (<0.001) 90.7 (0.011)
cTriclosan 5 × 10-5M 6.9 4.9 0.4 0.1 0.0 0.0 0.0 0.0 0.0 100.0 (ND) 98.8 (ND)
cCerulenin 5 × 10-5M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.0 (ND) 100.0 (ND)
a. Day 40 results based on 1 worm; 5 worms lost to microbial contamination
b. Day 40 results based on 2 worms; 4 worms lost to microbial contamination
c. Denotes compounds that were toxic to the monkey kidney cell feeder layer
The effects of exposure to a range of antibiotics on the viability of Onchocerca gutturosa adult males in long-term (40 day) in vitro culture. Viability 
was assessed by measuring worm motility scores throughout the trial and by MTT colorimetry on day 40.
Table 1: Summary of long-term trial 1: parasite mean motility scores and viability (MTT colorimetry) 
Compound/drug and conc. Mean motility scores over a period of 40 days Motility MTT
D A Y 1 5 1 01 52 02 53 03 54 0 %  r e d u c t i o n  o n  
day 40 (P)
% inhibition on 
day 40 (P)
Control 8.0 7.4 7.1 7.0 5.3 5.5 6.3 6.4 4.9
CGP 6140 1.25 × 10-5M (positive control) 0.5 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 100.0 (0.005) 83.3 (0.098)
Rifampicin 5 × 10-5M 7.7 6.8 6.7 6.8 3.2 1.7 0.2 0.2 0.0 100.0 (0.002) 89.6 (0.033)
Rifampicin 1.25 × 10-5M 7.0 7.0 7.3 5.7 6.5 5.2 5.7 5.0 5.6 0.0 (0.647) 0.0 (0.798)
Minocycline 5 × 10-5M 8.0 6.7 7.3 5.7 0.0 0.0 0.0 0.0 0.0 100.0 (0.002) 84.1 (0.042)
Minocycline 1.25 × 10-5M 7.8 7.5 6.7 5.7 4.3 2.5 4.8 1.7 0.0 100.0 (0.002) 93.7 (0.026)
Doxycycline 5 × 10-5M 8.3 8.0 8.0 5.7 0.3 0.0 0.0 0.0 0.0 100.0 (0.002) 93.0 (0.027)
Doxycycline 1.25 × 10-5M 7.3 6.5 6.3 4.8 6.3 6.3 6.2 6.2 5.5 0.0 (0.699) 0.0 (0.801)
Ethambutol 5 × 10-5M 6.8 6.8 6.5 6.7 4.0 4.8 4.3 5.0 2.7 44.9 (0.170) 73.0 (0.108)
Dapsone 5 × 10-5M 7.3 7.3 7.7 5.0 6.8 7.0 7.2 7.3 6.5 0.0 (0.250) 0.0 (0.798)
Pyrazinamide 5 × 10-5M 7.7 7.7 7.2 3.5 5.5 5.5 5.7 5.2 3.7 24.5 (0.503) 4.8 (0.949)
The effects of exposure to a range of antibiotics on the viability of Onchocerca gutturosa adult males in long-term (40 day) in vitro culture. Viability 
was assessed by measuring worm motility scores throughout the trial and by MTT colorimetry on day 40.Filaria Journal 2006, 5:4 http://www.filariajournal.com/content/5/1/4
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derived from A. albopictus eggs and is naturally infected
with Wolbachia pipientis [31]. The viability of neither cell
is affected by either the presence or absence of the bacte-
ria, since, unlike nematodes, insects do not have a mutu-
alistic association with their Wolbachia. To infect C6/36
cells, medium from a confluent culture of Aa23 cells was
collected, filtered through a 0.8 µm syringe filter to
remove any whole mosquito cells, and placed into a flask
of confluent C6/36 cells from which the medium had
been removed. The flask was agitated gently at room tem-
perature for 30 minutes before being incubated at 37°C in
an atmosphere of 5% CO2 in air. Infection of the cells with
the bacteria was confirmed by IFAT [17]. Hereafter the
infected cells will be termed C6/36 Wp. C6/36 and C6/36
Wp were grown in L-15 Leibovitz medium (Gibco) sup-
plemented with 2 mM L-glutamine, 1% non-essential
amino acids, 2% tryptose phosphate broth and 5% foetal
calf serum.
MTT reduction was compared with C6/36 and C6/36 Wp
cells each with and without tetracycline treatment (20 µg/
ml for up to four weeks, with medium changed every 3
days), with at least four repeats of 250 000 cells in each
group. The media were removed and the cells washed and
pelleted, then MTT was added to give a final concentration
of 0.5 mg/ml in phosphate buffered saline. After an incu-
bation of 1 hour at 37°C with 5% CO2, the cells were
washed and pelleted, and 200 µl dimethyl sulphoxide was
added to release the blue formazan reduction product.
The optical density of the samples was measured at 490
nm and the results expressed as mean optical density (±
S.D.). Student's t-test was used to compare differences
between two groups, with P values of < 0.05 considered to
be significant.
Results
In vitro drug screen
The motility scores and percentage inhibitions of MTT
reduction by all the tested compounds are shown in
Tables 1, 2 and 3. The positive control, CGP 6140, had a
very rapid onset of action, with reductions in worm motil-
ity even on the first day after initiation of treatment. No
worm movement was observed after day 15, and by day
40 there was a 67.4 to 83.3 inhibition in formazan forma-
tion compared to untreated controls. In contrast, the aver-
age motility score of the untreated control worms in each
experiment ranged from 4.9 to 7.2 at day 40 (Tables 1, 2
and 3).
Several anti-mycobacterial drugs were tested. Of these,
rifampicin (5 × 10-5M) was the most effective, completely
inhibiting motility by day 40 (Table 1 and Fig. 1) or day
25 (Table 3). Clofazimine (1.25 × 10-5M and 3.13 × 10-
6M) gradually affected worm motility so that, by day 40,
there were 100% and 88.9% reductions in motility, and
77.4 and 53.3 inhibition of MTT reduction, with the
higher and lower concentrations, respectively (Table 3
and Fig. 4). Ethambutol (5 × 10-5M) was less effective, giv-
ing 44.9% and 73% reductions in motility and MTT for-
mazan formation, respectively (Table 1 and Fig. 5).
However, the other agents with activity against Mycobacte-
rium species showed limited (pyrazinamide, isoniazid) or
no (dapsone) activity against the worms (Tables 1 and 3).
Also, the addition of isoniazid (5 × 10-5M) to rifampicin
(5 × 10-5M) did not improve the efficacy of the latter
(Table 3).
Doxycycline was effective (100% reduction in motility by
day 25, 93% inhibition of formazan formation at day 40)
at a concentration of 5 × 10-5M, but showed no activity at
Table 3: Summary of long-term trial 3: parasite mean motility scores and viability (MTT colorimetry) 
Compound/drug and conc. Mean motility scores over a period of 40 days Motility MTT
D A Y 1 5 1 01 52 02 53 03 54 0%  r e d u c t i o n  o n  
day 40 (P)
% inhibition on 
day 40 (P)
Control 8.4 8.3 7.6 7.5 7.8 7.7 7.6 7.2 7.2
CGP 6140 1.25 × 10-5M (positive control) 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.0 (<0.001) 67.4 (0.0032)
Rifampicin 5 × 10-5M 8.0 6.6 2.1 0.4 0.4 0.0 0.0 0.0 0.0 100.0 (<0.001) 67.4 (<0.001)
Erythromycin 5 × 10-5M 8.4 8.5 8.0 7.6 7.7 7.6 7.4 7.5 7.4 0.0 (0.539) 0.0 (0.210)
Oxytetracycline 5 × 10-5M 8.0 8.1 7.7 7.5 7.6 7.5 7.1 6.4 6.9 4.2 (0.360) 0.0 (0.995)
Isoniazid 5 × 10-5M 8.2 8.2 7.7 8.0 7.7 7.3 6.8 5.7 5.2 27.8 (0.010) 35.5 (0.074)
Isoniazid 5 × 10-5M + Rifampicin 5 × 10-5M 7.8 8.2 5.0 4.0 2.7 0.8 0.0 0.0 0.0 100.0 (<0.001) 71.7 (0.002)
Trimethoprim 5 × 10-5M 8.4 8.4 7.9 7.6 7.6 8.0 7.5 7.0 7.0 2.8 (0.549) 0.0 (0.319)
Sulphamethoxazole 5 × 10-5M 8.1 8.3 8.4 7.6 7.6 8.0 7.5 7.3 7.1 1.4 (0.848) 0.0 (0.998)
Trimeth. 5 × 10-5M + Sulphamethox. 5 × 10-5M 8.5 8.4 8.0 7.5 6.8 7.5 7.1 7.4 6.9 4.2 (0.449) 0.0 (0.828)
Clofazimine 1.25 × 10-5M 7.7 6.5 5.2 3.5 4.3 3.5 3.2 0.8 0.0 100.0 (<0.001) 77.4 (<0.001)
Clofazimine 3.13 × 10-6M 8.2 7.0 4.5 5.5 5.0 4.8 3.4 1.2 0.8 88.9 (<0.001) 53.3 (0.028)
The effects of exposure to a range of antibiotics and antibiotic combinations on the viability of Onchocerca gutturosa adult males in long-term (40 
day) in vitro culture. Viability was assessed by measuring worm motility scores throughout the trial and by MTT colorimetry on day 40.Filaria Journal 2006, 5:4 http://www.filariajournal.com/content/5/1/4
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1.25 × 10-5M (Fig. 3). However, minocycline was filari-
cidal at both of these concentrations (Fig. 2). Intermediate
activity was shown by norfloxacin, ciprofloxacin, vanco-
mycin and gentamycin (all at a concentration of 5 × 10-
5M). The drugs that did not have a filaricidal effect at 5 ×
10-5M included erythromycin, oxytetracycline, trimetho-
prim and sulphamethoxazole (these two either alone or
in combination).
Two compounds, triclosan and cerulenin, were toxic to
the monkey kidney cell feeder layer, so it was not possible
to conclude if they had an anti-Onchocerca effect, since a
viable cell layer is essential to the long-term survival of the
worms.
Contribution of Wolbachia to the MTT reduction assay
C6/36 cells with and without W. pipientis infection were
incubated in medium or medium plus tetracycline for two
or four weeks before being analysed by the MTT reduction
assay. This assay showed that infection with Wolbachia did
contribute to extra metabolic activity in the cells, since
C6/36 Wp had significantly higher absorbance readings
than C6/36 (P = 0.017 after two weeks' incubation; P =
0.000 after four weeks' incubation, Fig. 6). However, in
C6/36 Wp treated with tetracycline for two to four weeks
the absorbance was no different from C6/36 with tetracy-
cline (P = 0.269 at two weeks; P = 0.475 at four weeks). At
neither time-point did uninfected C6/36 treated with tet-
Mean motility score of O. gutturosa adult males in vitro  exposed to doxycycline Figure 3
Mean motility score of O. gutturosa adult males in 
vitro exposed to doxycycline. Control, ❍ ; doxycycline 5 
× 10-5M, ■ ; doxycycline 1.25 × 10-5M, ● ; CGP 6140 1.25 × 
10-5M,  (positive control). (Data from Table 1).
Mean motility score of O. gutturosa adult males in vitro  exposed to rifampicin Figure 1
Mean motility score of O. gutturosa adult males in 
vitro exposed to rifampicin. Control, ❍ ; rifampicin 5 × 
10-5M, ■  rifampicin 1.25 × 10-5M, ● ; CGP 6140 1.25 × 10-
5M,  (positive control). (Data from Table 1).
Mean motility score of O. gutturosa adult males in vitro  exposed to minocycline Figure 2
Mean motility score of O. gutturosa adult males in 
vitro exposed to minocycline. Control, ❍ ; minocycline 5 
× 10-5M, ■ ; minocycline 1.25 × 10-5M, ● ; CGP 6140 1.25 × 
10-5M,  (positive control). (Data from Table 1).Filaria Journal 2006, 5:4 http://www.filariajournal.com/content/5/1/4
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racycline show a significant difference from those not
treated (P = 0.958 at two weeks; P = 0.543 at four weeks,
Fig. 6), indicating that the tetracycline itself had no effect
in reducing the metabolic activity.
Discussion
The results presented here confirm that O.gutturosa males
provide a suitable in vitro screen for slow-acting antibiotic
drugs with macrofilaricidal activity. Male O.gutturosa are
smaller than O.volvulus males but contain an almost iden-
tical Wolbachia/nematode ratio (H.F. McGarry and M.J.
Taylor, unpublished observation) indicating that they are
a suitable model for human onchocerciasis.
The gradual reduction in motility (as with clofazimine) or
a delay before effects were seen (rifampcin, doxycycline,
minocycline) is consistent with activity against the endo-
symbionts, in contrast to the direct and rapid effects on
worm viability of the positive control, Amocarzine. Inter-
estingly, with rifampcin, doxycycline, minocycline and
ethambutol, the most rapid decline in worm motility
occurred between 15 and 20 days of treatment. This
period of treatment may be sufficient to inhibit Wol-
bachia-dependent processes, such as inhibition of protein
synthesis (which is the mode of action of tetracyclines),
with a resultant deterioration in nematode health before
Wolbachia contribute to metabolic activity as measured by  the MTT reduction assay Figure 6
Wolbachia contribute to metabolic activity as meas-
ured by the MTT reduction assay C6/36 and C6/36 Wp 
were incubated in medium or medium with tetracycline 20 
µg/ml for four weeks before the MTT reduction assay was 
performed. Bars represent means of five repeats each of 250 
000 cells (± S.D.). Values that are significantly lower than 
those of C6/36 Wp are denoted by * (P = 0.000) and ** (P = 
0.03).
Mean motility score of O. gutturosa adult males in vitro  exposed to clofazimine Figure 4
Mean motility score of O. gutturosa adult males in 
vitro exposed to clofazimine. Control, ❍ ; clofazimine 
1.25 × 10-5M, ■ ; clofazimine 3.13 × 10-6M, ● ; CGP 6140 
1.25 × 10-5M,  (positive control). (Data from Table 3).
Mean motility score of O. gutturosa adult males in vitro  exposed to ethambutol Figure 5
Mean motility score of O. gutturosa adult males in 
vitro exposed to ethambutol. Control,❍ ; ethambutol 5 × 
10-5M, ● ; CGP 6140 1.25 × 10-5M,  (positive control). 
(Data from Table 1).Filaria Journal 2006, 5:4 http://www.filariajournal.com/content/5/1/4
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a decline in bacterial numbers is observable. As such, this
O. gutturosa system is likely to be more sensitive than one
that utilises Wolbachia-infected mosquito cell lines, which
relies on direct observation for the presence or absence of
bacteria [27,32].
Currently, doxycycline (200 mg) administered daily for
three weeks is the shortest effective regimen that has been
tried against a human filarial infection; when followed by
standard anti-filarial chemotherapy, this treatment
resulted in prolonged reductions in microfilaraemia and
in Wolbachia numbers in the microfilariae, but was not
macrofilaricidal [20] and is similar to the timeframe after
which effects were observable in vitro.
Rifampicin has previously been shown to be very effective
against Wolbachia [6,27,32,33], which was confirmed in
this in vitro antifilarial assay. Rifampicin interferes with
nucleic acid synthesis by combining with and inhibiting
the RNA-polymerase of bacteria and is bactericidal. The
anti-leprosy agent clofazimine also demonstrated good
activity against O. gutturosa, and is also bactericidal. Anti-
tuberculosis and -leprosy therapies may have benefits at
the population level by reducing the prevalence of filaria-
sis [34]. However, the other drugs tested that are used
against  Mycobacterium  species (ethambutol, dapsone,
pyrazinamide, isoniazid) showed little anti-Onchocerca
activity.
The tetracycline doxycycline was filaricidal in this drug
screen, confirming previous findings that it has anti-Wol-
bachia effects [27, 33, 35]. This drug has also been used in
human filarial infections, in which it has resulted in a pro-
longed loss of microfilariae and lack of embryogenesis
[10,11,14], and has recently been shown to be macrofila-
ricidal against W. bancrofti [13]. In the present work mino-
cycline was even more effective than doxycycline and
warrants further investigation in vivo. This result agrees
with our unpublished work (S. Townson) that minocy-
cline is more active than doxycycline against O. lienalis
microfilariae in mice. Minocycline has the advantage over
doxycycline of inducing less phototoxicity. However,
oxytetracycline showed no anti-Wolbachia activity, in con-
trast to previous reports [6,9,32]; it is not clear why there
were contradictory findings. The lack of activity by other
compounds (erythromycin, trimethoprim and sulphame-
thoxazole) was consistent with previous findings [27, 36].
Filarial nematodes cultured in vitro often succumb to drug
treatments more readily than they do in vivo. The system
described here provides a relatively easy and inexpensive
way to perform a primary or secondary screen of com-
pounds for anti-filarial/Wolbachia activity, which would
then be followed by in vivo experiments. Antibiotics are
slow-acting against filarial nematodes, as seen in the
present study and in field trials (for example, [12,13]); an
advantage of the male O. gutturosa culture system is that it
can be maintained for at least 40 days. In the present study
the effects of the compounds has not been directly related
to their activity against Wolbachia and it is possible that
they also had direct anti-nematodal activity. Studies on
the dynamics of the loss of the bacteria from worms are
currently underway using quantitative polymerase chain
reaction and/or immunohistology in the screening sys-
tem.
The presence of Wolbachia made a significant contribution
to the MTT assay in C6/36 cells as would be predicted
from the presence of succinate dehydrogenase as deter-
mined by genomic annotation. Thus partial reduction in
formazan formation in MTT assays could reflect either the
loss of bacteria and retention of worm viability or vice
versa. Should an in vitro screen for specific activity against
either the bacteria or worm be required then alternative
markers of viability may need to be developed [37].
Conclusion
This study has demonstrated that the in vitro screen for
macrofilaricidal activity, which uses the culture of male O.
gutturosa, can be successfully extended and is also valid for
the screening of antibiotic compounds with potential
anti-Wolbachia/filarial activity. This system can be used for
long-term screening, in this case for 40 days. Rifampicin
and doxycycline were two of the most active antibiotics
tested in this screen, in agreement with previous findings.
However, a new finding was that minocycline was more
quickly and completely effective than either of these com-
pounds. It was also found that Wolbachia contribute to the
MTT formazan formation which is used as a marker of
filarial worm viability, suggesting that bacteria contribute
directly to the metabolic activity of the nematode and that
it may be necessary to reassess alternative indicators of
worm and or bacterial viability.
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